|
Senti Biosciences Inc (NASDAQ: SNTI) |
|
Senti Biosciences Inc
SNTI's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Senti Biosciences Inc 's sales fell
in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 2232
Biotechnology & Pharmaceuticals industry recorded
growth of revenues by 13.29 %
Senti Biosciences Inc net loss increased from $-19 millions, to $-29 millions in III. Quarter 2024,
• More on SNTI's Growth
|
|
Senti Biosciences Inc realized a net loss in trailing twelve months.
Senti Biosciences Inc realized cash reduction of $ -8.86 per share in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 76.24.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.38.
• More on SNTI's Valuation
|
|
|
|
|
Senti Biosciences Inc realized net loss in trailing twelve months.
Senti Biosciences Inc realized cash outflow of $ -8.86per share in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 76.24.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.38.
Senti Biosciences Inc Price to Book Ratio is at 1.61 higher than Industry Avg. of -0, and higher than S&P 500 Avg. of 0.01
• More on SNTI's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com